Generic name |
rifaximin |
|
---|---|---|
Strength |
550 mg |
|
Form |
oral tablet |
Special Authority criteria |
Approval period |
---|---|
For reducing the risk of overt hepatic encephalopathy (HE) recurrence in patients who meet the following criteria:
AND
AND
Rifaximin should be used in combination with a maximal tolerated dose of lactulose. |
6 months |